To examine current and emerging technologies for assessing postoperative recurrence in Crohn’s disease.
Key Findings:
Postoperative recurrence occurs in up to 70% of patients within 1 year after surgery.
Ileocolonoscopy is the reference standard, but clinical symptoms often do not correlate with inflammation.
Composite strategies combining biomarkers with imaging are more effective than single measures.
Advanced endoscopic techniques can detect early mucosal changes linked to recurrence.
Intestinal ultrasound shows strong correlation with endoscopic findings when combined with biomarkers.
Interpretation:
Emerging technologies and AI integration could enhance monitoring strategies, shifting from reactive to proactive approaches in managing postoperative Crohn’s disease recurrence.
Limitations:
Current monitoring tools have variability in reliability and optimal cutoff values.
Many advanced techniques are not widely available and require specialized centers.
Standardized scoring systems for imaging modalities are still under development.
Conclusion:
Combining advanced imaging with AI and multi-omics data may improve personalized monitoring strategies, leading to better long-term outcomes for Crohn’s disease patients.
